Zig Zag and Stoker products performed well in an otherwise challenging business environment. Read More
The uncertainty around the FDA ban has made it difficult for Juul to secure financing for legal settlements.Read More
Uncertainty about Juul’s ability to market product could make it difficult to pay for legal settlements.Read More
Newly issued operating licenses and product approvals demonstrate the firm’s operational excellence, says CEO Wang. Read More
The AIM-traded firm told shareholders that it delivered a strong performance for the year ended March 31.Read More
A recent court ruling alleviated a significant barrier to the company’s adult-focused B2B sales efforts.Read More
The company says it also submitted PMTAs for more than 700 additional synthetic nicotine products.Read More
Altria reduced the value of its investment in Juul Labs nearly 70 percent of its original $12.8 billion.Read More
The company received $259 million of revenue for the quarter ended March 31, reports Bloomberg.Read More
A recent distribution deal with PMI will likely turbocharge the Bidi Stick’s global distribution. Read More
